Contributors |
|
xix | |
About the Editors |
|
xxiii | |
Foreword |
|
xxv | |
Preface |
|
xxvii | |
|
1 Strategies to improve the expression and solubility of recombinant proteins in E. coli |
|
|
|
|
|
|
|
1 | (1) |
|
2 Before starting with protein expression |
|
|
2 | (2) |
|
|
4 | (1) |
|
4 Standard protocol for recombinant protein expression in E. coli |
|
|
5 | (1) |
|
4.1 For protein solubilization |
|
|
5 | (1) |
|
4.2 For protein purification |
|
|
5 | (1) |
|
5 Troubleshooting strategies |
|
|
6 | (4) |
|
5.1 Handling protein expression and solubility issues |
|
|
6 | (3) |
|
5.2 Handling of inclusion bodies |
|
|
9 | (1) |
|
5.3 Handling protein leakage |
|
|
9 | (1) |
|
5.4 Handling of toxic proteins |
|
|
9 | (1) |
|
5.5 Handling of unstable proteins |
|
|
10 | (1) |
|
5.6 Posttranslational modifications |
|
|
10 | (1) |
|
6 Conclusion and future perspectives |
|
|
10 | (3) |
|
|
10 | (3) |
|
2 Advances in heterologous protein expression strategies in yeast and insect systems |
|
|
|
|
|
|
|
|
13 | (1) |
|
2 Heterologous protein expression strategies in yeast systems |
|
|
13 | (8) |
|
|
13 | (1) |
|
2.2 Synthetic gene optimization |
|
|
14 | (1) |
|
2.3 Expression optimization by controlling gene copy number |
|
|
14 | (1) |
|
2.4 Optimization of promoters |
|
|
15 | (1) |
|
2.5 Engineering yeast secretion pathway |
|
|
16 | (5) |
|
2.6 Conclusion of yeast expression systems |
|
|
21 | (1) |
|
3 Heterologous protein expression strategies in insect systems |
|
|
21 | (4) |
|
|
21 | (1) |
|
3.2 Growth factors and in vitro culture |
|
|
22 | (1) |
|
|
22 | (1) |
|
3.4 Use of novel or genetically improved cell lines |
|
|
23 | (1) |
|
3.5 Baculovirus insect cell expression system |
|
|
24 | (1) |
|
3.6 Baculovirus-free insect cell expression system |
|
|
25 | (1) |
|
4 Conclusion of baculovirus expression systems |
|
|
25 | (6) |
|
|
25 | (1) |
|
|
26 | (5) |
|
3 Methods for transient expression and purification of monoclonal antibodies in mammalian cells |
|
|
|
|
|
|
|
|
31 | (1) |
|
2 Background experimental preparation |
|
|
32 | (2) |
|
2.1 Plasmid DNA extraction protocol step-by-step |
|
|
34 | (1) |
|
2.2 Agarose gel preparation |
|
|
34 | (1) |
|
3 Materials required for antibody purification |
|
|
34 | (1) |
|
4 Detailed step-by-step protocol for antibody purification |
|
|
35 | (2) |
|
|
35 | (2) |
|
|
37 | (1) |
|
5 Troubleshooting problems |
|
|
37 | (1) |
|
5.1 Optimization of cell transfection |
|
|
37 | (1) |
|
|
37 | (1) |
|
5.3 Postpurification storage of the protein |
|
|
38 | (1) |
|
5.4 Precautions, recommendations, and general troubleshooting |
|
|
38 | (1) |
|
|
38 | (3) |
|
|
38 | (3) |
|
4 Methods for recombinant production and purification of intrinsically disordered proteins |
|
|
|
|
|
41 | (1) |
|
1.1 Timing: 1 day to 1 month, depending on the gene of interest cloned in an expression plasmid |
|
|
41 | (1) |
|
2 Materials and equipment |
|
|
41 | (1) |
|
3 Step-by-step method details |
|
|
42 | (2) |
|
3.1 Bacterial growth and protein expression |
|
|
42 | (1) |
|
|
43 | (1) |
|
|
43 | (1) |
|
3.4 Optional steps---Isotopic labeling |
|
|
44 | (1) |
|
|
44 | (1) |
|
5 Optimization and troubleshooting |
|
|
44 | (5) |
|
|
47 | (2) |
|
5 Methods to determine the oligomeric structure of proteins |
|
|
|
|
|
|
|
49 | (1) |
|
2 Electrophoretic methods |
|
|
50 | (3) |
|
|
50 | (1) |
|
2.2 Chemical crosslinking with glutaraldehyde followed by SDS-PAGE |
|
|
50 | (3) |
|
3 Size exclusion chromatography |
|
|
53 | (1) |
|
|
53 | (1) |
|
|
53 | (1) |
|
|
54 | (1) |
|
4 Dynamic light scattering |
|
|
54 | (2) |
|
|
56 | (1) |
|
|
56 | (1) |
|
5 Circular dichroism spectroscopy |
|
|
56 | (2) |
|
|
58 | (1) |
|
6 Fluorescence-based methods |
|
|
58 | (7) |
|
6.1 Fluorescence correlation spectroscopy |
|
|
58 | (2) |
|
6.2 Fluorescence resonance energy transfer |
|
|
60 | (2) |
|
6.3 Fluorescence fluctuation spectroscopy |
|
|
62 | (1) |
|
6.4 Fluorescence recovery after photobleaching |
|
|
62 | (1) |
|
6.5 Bimolecular fluorescence complementation assay |
|
|
63 | (1) |
|
|
64 | (1) |
|
7 Analytical ultracentrifugation |
|
|
65 | (1) |
|
|
66 | (1) |
|
8 X-ray crystallography and NMR spectroscopy |
|
|
66 | (2) |
|
|
68 | (1) |
|
|
68 | (1) |
|
10 Atomic force microscopy |
|
|
69 | (1) |
|
|
69 | (1) |
|
11 Co-immunoprecipitation |
|
|
69 | (1) |
|
|
70 | (1) |
|
|
70 | (1) |
|
|
71 | (6) |
|
|
71 | (6) |
|
6 Multimodal methods to study protein aggregation and fibrillation |
|
|
|
|
|
|
|
|
77 | (2) |
|
1.1 Protein misfolding and aggregation |
|
|
77 | (1) |
|
1.2 Multilevel approach to close the gap between the in vitro to the in vivo aggregation processes |
|
|
77 | (2) |
|
2 Combination of in vitro techniques to evaluate isolated protein aggregates and fibrils |
|
|
79 | (10) |
|
2.1 Structural and morphological analysis of protein aggregates and fibrils by the combination of low-resolution methods |
|
|
79 | (6) |
|
2.2 Implementation of atomistic methods to reveal the structure of aggregates and fibrils |
|
|
85 | (4) |
|
3 Multimodal methods to evaluate the aggregation of proteins in cells tissues and living system |
|
|
89 | (14) |
|
3.1 Protein aggregation studies in cells |
|
|
89 | (3) |
|
3.2 Protein aggregation studies in tissues |
|
|
92 | (3) |
|
3.3 Protein aggregation studies in animal models or in vivo |
|
|
95 | (1) |
|
|
95 | (1) |
|
|
95 | (8) |
|
7 Experimental methods to study the thermodynamics of protein--protein interactions |
|
|
|
|
|
|
|
|
103 | (1) |
|
2 Criteria for forming a protein-protein interaction |
|
|
103 | (1) |
|
3 Characteristic features of PPI interfaces |
|
|
103 | (2) |
|
3.1 Interface shape and size |
|
|
103 | (1) |
|
|
104 | (1) |
|
3.3 Structural motifs and secondary structures |
|
|
104 | (1) |
|
3.4 Driving forces of interaction |
|
|
105 | (1) |
|
|
105 | (1) |
|
|
105 | (1) |
|
|
105 | (1) |
|
|
105 | (1) |
|
4 Thermodynamic parameters associated with PPI |
|
|
105 | (2) |
|
4.1 Gibbs free energy, enthalpy, entropy, and heat capacity |
|
|
105 | (1) |
|
4.2 Enthalpy--entropy compensation, cooperativity, and flexibility |
|
|
106 | (1) |
|
4.3 Solvation and desolvation effects |
|
|
106 | (1) |
|
5 Techniques to study the thermodynamics of PPI |
|
|
107 | (6) |
|
5.1 Isothermal titration calorimetry |
|
|
107 | (2) |
|
5.2 Differential scanning calorimetry |
|
|
109 | (1) |
|
5.3 Microscale thermophoresis |
|
|
110 | (3) |
|
|
113 | (2) |
|
|
113 | (2) |
|
8 Experimental methods to study the kinetics of protein-protein interactions |
|
|
|
|
|
|
|
115 | (1) |
|
2 Surface plasmon resonance |
|
|
115 | (2) |
|
|
115 | (1) |
|
|
116 | (1) |
|
|
116 | (1) |
|
|
117 | (1) |
|
|
117 | (1) |
|
3 Bio-layer interferometry |
|
|
117 | (2) |
|
|
117 | (1) |
|
|
118 | (1) |
|
|
118 | (1) |
|
|
118 | (1) |
|
|
119 | (1) |
|
4 Microscale thermophoresis |
|
|
119 | (2) |
|
|
119 | (1) |
|
|
119 | (1) |
|
|
119 | (1) |
|
|
120 | (1) |
|
|
120 | (1) |
|
5 Isothermal titration calorimetry |
|
|
121 | (1) |
|
|
121 | (1) |
|
|
121 | (1) |
|
|
122 | (1) |
|
|
122 | (1) |
|
|
122 | (1) |
|
6 Quartz crystal microbalance |
|
|
122 | (1) |
|
|
122 | (1) |
|
|
122 | (1) |
|
|
123 | (1) |
|
|
123 | (1) |
|
|
123 | (1) |
|
|
123 | (2) |
|
|
123 | (1) |
|
|
124 | (1) |
|
9 Computational techniques for studying protein-protein interactions |
|
|
|
|
|
|
125 | (1) |
|
2 Types of protein-protein complexes |
|
|
125 | (1) |
|
3 PPIs as targets for drug discovery |
|
|
126 | (1) |
|
|
126 | (1) |
|
5 Computational techniques in PPI detection |
|
|
127 | (5) |
|
5.1 Sequence-based techniques |
|
|
127 | (1) |
|
5.2 Structure-based techniques |
|
|
128 | (2) |
|
5.3 Gene fusion-based approach |
|
|
130 | (1) |
|
5.4 In silico two-hybrid techniques |
|
|
130 | (1) |
|
5.5 Mirrortree-based technique |
|
|
130 | (1) |
|
5.6 Phylogenetic tree-based technique |
|
|
131 | (1) |
|
5.7 Phylogenetic profile-based technique |
|
|
131 | (1) |
|
5.8 Chromosome proximity/gene neighborhood-based technique |
|
|
131 | (1) |
|
5.9 Network topology-based technique |
|
|
131 | (1) |
|
5.10 Gene expression-based technique |
|
|
131 | (1) |
|
6 Comparison of available computational approaches |
|
|
132 | (1) |
|
|
132 | (1) |
|
8 PPI network and visualization |
|
|
132 | (1) |
|
9 Conclusion and future perspectives |
|
|
133 | (4) |
|
|
133 | (4) |
|
10 Experimental methods to study protein--nucleic acid interactions |
|
|
|
|
|
|
|
137 | (1) |
|
2 Single-molecule approaches for the identification and validation of protein--nucleic acid interactions |
|
|
138 | (5) |
|
2.1 Methods to determine the kinetics and dynamics of the interactions |
|
|
139 | (2) |
|
2.2 Methods to determine structural characteristics of the interactions |
|
|
141 | (2) |
|
3 Investigation of protein--nucleic acid interactions in mammalian cell lines |
|
|
143 | (9) |
|
3.1 Methods to study protein--DNA interaction |
|
|
143 | (4) |
|
3.2 Methods to study protein--RNA interactions |
|
|
147 | (5) |
|
|
152 | (11) |
|
|
152 | (11) |
|
11 Advanced computational tools for quantitative analysis of protein--nucleic acid interfaces |
|
|
|
|
|
|
163 | (1) |
|
2 Datasets for studying protein--RNA interfaces |
|
|
164 | (2) |
|
2.1 Protein--RNA docking benchmarks |
|
|
164 | (1) |
|
2.2 Protein--RNA affinity benchmarks |
|
|
165 | (1) |
|
2.3 Databases of protein--RNA interactions |
|
|
165 | (1) |
|
3 Tools for the analysis of protein--RNA interfaces |
|
|
166 | (2) |
|
4 Tools for protein--RNA binding site prediction |
|
|
168 | (1) |
|
5 Tools for protein--RNA binding affinity prediction |
|
|
168 | (1) |
|
6 Tools for hot spots at protein--RNA interfaces |
|
|
169 | (1) |
|
7 A brief survey of tools for studying protein--DNA interactions |
|
|
170 | (1) |
|
|
171 | (10) |
|
|
172 | (1) |
|
|
172 | (9) |
|
12 Experimental techniques to study protein dynamics and conformations |
|
|
|
|
|
|
|
|
|
|
181 | (1) |
|
2 Various methods to study protein dynamics and conformations |
|
|
181 | (14) |
|
2.1 Nuclear magnetic resonance spectroscopy |
|
|
182 | (2) |
|
2.2 Cryo-electron microscopy |
|
|
184 | (3) |
|
2.3 Small-angle X-ray scattering/small-angle neutron scattering |
|
|
187 | (2) |
|
|
189 | (1) |
|
2.5 Single-molecule fluorescence resonance energy transfer (smFRET) |
|
|
190 | (3) |
|
2.6 Atomic force microscopy |
|
|
193 | (2) |
|
3 Conclusion and future perspectives |
|
|
195 | (4) |
|
|
196 | (3) |
|
13 Computational techniques to study protein dynamics and conformations |
|
|
|
|
|
|
|
199 | (1) |
|
2 "Realistic" methods: Molecular dynamics and enhanced sampling |
|
|
200 | (1) |
|
3 "Simplified" approaches: Coarse-graining and path-sampling algorithms |
|
|
201 | (3) |
|
3.1 Coarse-grained normal mode analysis (NMA) |
|
|
201 | (1) |
|
3.2 Langevin and Brownian dynamics (BD) |
|
|
202 | (1) |
|
3.3 Discrete molecular dynamics (dMD) |
|
|
203 | (1) |
|
3.4 Coarse-grained molecular dynamics |
|
|
203 | (1) |
|
4 A case study: The open-to-close transition of the ribose-binding protein |
|
|
204 | (3) |
|
4.1 Classical and replica-exchange molecular dynamics simulations |
|
|
205 | (1) |
|
4.2 Coarse-grain (CG) MARTINI simulations |
|
|
205 | (1) |
|
4.3 Discrete molecular dynamics-PACSAB simulations |
|
|
205 | (1) |
|
4.4 Comparative analysis of conformational sampling |
|
|
206 | (1) |
|
5 Summary and conclusions |
|
|
207 | (6) |
|
|
207 | (1) |
|
|
207 | (6) |
|
14 Application of circular dichroism spectroscopy in studying protein folding, stability and interaction |
|
|
|
|
|
|
|
|
213 | (1) |
|
2 Theory of circular dichroism |
|
|
214 | (1) |
|
3 Application of CD spectroscopy |
|
|
215 | (5) |
|
3.1 Estimation of secondary structures |
|
|
215 | (1) |
|
3.2 Thermal denaturation studies |
|
|
216 | (1) |
|
3.3 Urea and GdmCI-induced denaturation studies |
|
|
216 | (3) |
|
3.4 Measurement of the impact of osmolyte in protein stability |
|
|
219 | (1) |
|
3.5 Impact of crowding agents in protein stability |
|
|
220 | (1) |
|
3.6 Protein--DNA and protein--ligand interactions |
|
|
220 | (1) |
|
4 Time-resolved CD spectroscopy and its uses in protein folding kinetics |
|
|
220 | (1) |
|
5 Conclusion and future perspectives |
|
|
221 | (4) |
|
|
221 | (1) |
|
|
221 | (4) |
|
15 Studying protein-folding dynamics using single-molecule fluorescence methods |
|
|
|
|
Krishnananda Chattopadhyay |
|
|
|
|
225 | (1) |
|
2 Single-molecule fluorescence techniques for protein-folding dynamics |
|
|
226 | (8) |
|
2.1 Theory of single-molecule fluorescence |
|
|
226 | (1) |
|
2.2 Fluorescence correlation spectroscopy (FCS) |
|
|
227 | (4) |
|
2.3 Single-molecule fluorescence resonance energy transfer (smFRET) |
|
|
231 | (2) |
|
2.4 Single-molecule fluorescence microscopy (SMFM) |
|
|
233 | (1) |
|
3 Conclusion and future perspectives |
|
|
234 | (3) |
|
|
235 | (2) |
|
16 Advances in liquid-state NMR spectroscopy to study the structure, function, and dynamics of biomacromolecules |
|
|
|
|
|
|
1 Introduction to liquid-state NMR spectroscopy |
|
|
237 | (4) |
|
1.1 Recent advancements in NMR hardware |
|
|
237 | (4) |
|
2 Liquid-state NMR spectroscopy of biomacromolecules |
|
|
241 | (14) |
|
2.1 Sequence-specific resonance assignments |
|
|
241 | (7) |
|
|
248 | (1) |
|
2.3 Structure determination |
|
|
249 | (4) |
|
2.4 Dynamics of biomacromolecules |
|
|
253 | (2) |
|
3 Biomolecular behavior and drug discovery |
|
|
255 | (3) |
|
3.1 Biomacromolecular interactions |
|
|
255 | (2) |
|
3.2 Biomacromolecular hydration |
|
|
257 | (1) |
|
3.3 NMR of biologies and biosimilars |
|
|
258 | (1) |
|
4 NMR of biomacromolecules in living cells |
|
|
258 | (1) |
|
4.1 Structure determination in the living cell |
|
|
258 | (1) |
|
4.2 In-cell drug discovery |
|
|
259 | (1) |
|
|
259 | (8) |
|
|
259 | (8) |
|
17 In-cell NMR spectroscopy: A tool to study cellular structure biology |
|
|
|
|
|
267 | (1) |
|
2 Overview of in-cell NMR |
|
|
267 | (2) |
|
3 Bioreactor systems for in-cell NMR observations |
|
|
269 | (1) |
|
4 Applications of in-cell NMR |
|
|
269 | (4) |
|
5 Conclusion and future perspectives |
|
|
273 | (4) |
|
|
273 | (4) |
|
18 Current trends in membrane protein crystallography |
|
|
|
|
|
|
|
|
|
|
277 | (1) |
|
1.1 Basics of protein crystallography |
|
|
277 | (1) |
|
1.2 Membrane protein crystallography |
|
|
277 | (1) |
|
2 Expression screening of membrane proteins for crystallization |
|
|
278 | (1) |
|
3 Detergent screening and fluorescence size exclusion chromatography of membrane proteins |
|
|
279 | (1) |
|
4 Crystallization of membrane proteins |
|
|
279 | (3) |
|
|
279 | (2) |
|
4.2 Lipidic cubic phase crystallization |
|
|
281 | (1) |
|
4.3 Bicelle crystallization |
|
|
282 | (1) |
|
4.4 In situ crystallography |
|
|
282 | (1) |
|
5 Engineering membrane proteins to facilitate crystal formation |
|
|
282 | (1) |
|
|
282 | (3) |
|
|
285 | (1) |
|
8 Time-resolved crystallography |
|
|
285 | (1) |
|
9 X-ray free-electron laser |
|
|
285 | (2) |
|
10 Conclusion and future perspectives |
|
|
287 | (4) |
|
|
288 | (1) |
|
|
288 | (3) |
|
19 Advances in sample preparation and data processing for single-particle cryo-electron microscopy |
|
|
|
|
|
|
|
291 | (2) |
|
2 Sample quality is the key to high-resolution structure determination |
|
|
293 | (4) |
|
2.1 Sample preparation for SPA |
|
|
293 | (1) |
|
2.2 Tools and reagents to facilitate structure determination of membrane proteins |
|
|
293 | (3) |
|
2.3 Strategies for sample preparation of macromolecular assemblies |
|
|
296 | (1) |
|
2.4 Low molecular weight specimens |
|
|
296 | (1) |
|
3 Grid preparation for SPA |
|
|
297 | (3) |
|
|
297 | (1) |
|
3.2 Mesh size of the grids |
|
|
297 | (1) |
|
|
297 | (1) |
|
|
298 | (1) |
|
3.5 Grid treatment and modifications to improve particle distribution and orientation |
|
|
298 | (1) |
|
|
299 | (1) |
|
|
300 | (1) |
|
5 Advances in SPA data collection and processing |
|
|
301 | (2) |
|
|
301 | (1) |
|
|
301 | (1) |
|
|
302 | (1) |
|
5.4 Particle detection and selection |
|
|
302 | (1) |
|
|
302 | (1) |
|
5.6 Ab initio 3D reconstruction and refinement |
|
|
303 | (1) |
|
6 AI/ML-based approaches in cryoEM data processing pipeline |
|
|
303 | (2) |
|
7 Conclusion and future perspectives |
|
|
305 | (6) |
|
|
306 | (1) |
|
|
306 | (1) |
|
|
306 | (1) |
|
|
306 | (5) |
|
20 Advanced mass spectrometry-based methods for protein molecular-structural biologists |
|
|
|
|
|
|
|
|
311 | (2) |
|
2 Data-independent acquisitions (DIA) for accurate protein quantification |
|
|
313 | (5) |
|
2.1 Selected recent DIA strategies |
|
|
313 | (1) |
|
2.2 Bioinformatic processing of DIA data |
|
|
314 | (1) |
|
2.3 DDA-based spectral libraries, sample-specific |
|
|
315 | (1) |
|
2.4 DDA-based spectral libraries, public resources |
|
|
315 | (1) |
|
2.5 Challenges and opportunities related to DDA-based spectral libraries |
|
|
316 | (1) |
|
2.6 Spectral library-free workflows |
|
|
316 | (1) |
|
2.7 Alternative library strategies for DIA data analysis |
|
|
317 | (1) |
|
3 Resolving protein structures using DIA-MS |
|
|
318 | (3) |
|
3.1 Protein structures and posttranslational modifications |
|
|
318 | (1) |
|
3.2 Determination of different protein conformations using DIA-MS |
|
|
319 | (2) |
|
4 Conclusions and outlooks |
|
|
321 | (6) |
|
|
322 | (1) |
|
|
322 | (5) |
|
21 Developments, advancements, and contributions of mass spectrometry in omics technologies |
|
|
|
|
|
327 | (4) |
|
2 Omics mass spectrometry |
|
|
331 | (7) |
|
|
331 | (5) |
|
2.2 Mass analyzers-Now and then |
|
|
336 | (2) |
|
3 Mass spectrometry in Omics technologies |
|
|
338 | (9) |
|
3.1 Proteomics and mass spectrometry |
|
|
338 | (7) |
|
3.2 Metabolomics and mass spectrometry |
|
|
345 | (2) |
|
4 Recent developments in the mass spectrometer |
|
|
347 | (1) |
|
5 Fragmentation principles |
|
|
348 | (5) |
|
5.1 Collision-induced dissociation (CID) |
|
|
349 | (1) |
|
5.2 Higher energy collisional dissociation (HCD) |
|
|
349 | (1) |
|
5.3 Electron transfer dissociation (ETD) |
|
|
350 | (1) |
|
5.4 ETcaD; EThCD---Hybrid dissociation techniques |
|
|
351 | (2) |
|
5.5 Ultraviolet photodissociation (UVPD) |
|
|
353 | (1) |
|
6 Conclusion and future perspectives |
|
|
353 | (4) |
|
|
353 | (4) |
|
22 Role of structural biology methods in drug discovery |
|
|
|
|
|
|
357 | (1) |
|
2 Structural biology aided selection of drug targets |
|
|
357 | (2) |
|
3 Role of experimental and computational approaches in drug discovery |
|
|
359 | (6) |
|
3.1 X-ray crystallography |
|
|
359 | (3) |
|
|
362 | (1) |
|
3.3 Cryogenic electron microscopy (cryo-EM) |
|
|
363 | (1) |
|
3.4 Comparative modeling and QSAR studies |
|
|
364 | (1) |
|
|
365 | (1) |
|
5 Enhancement of ligand specificity |
|
|
366 | (1) |
|
6 Optimization of hits and drug-likeness |
|
|
367 | (1) |
|
7 Development of peptidomimetics |
|
|
367 | (1) |
|
8 Conclusion and future perspectives |
|
|
368 | (5) |
|
|
368 | (5) |
|
23 Prediction, validation, and analysis of protein structures: A beginner's guide |
|
|
|
|
|
|
373 | (1) |
|
2 Protein structure modeling |
|
|
374 | (3) |
|
2.1 Template-based modeling |
|
|
374 | (3) |
|
2.2 Template-free modeling |
|
|
377 | (1) |
|
3 Protein structure refinement and validation |
|
|
377 | (3) |
|
3.1 SWISS-MODEL validation |
|
|
377 | (1) |
|
|
378 | (1) |
|
3.3 General validation of models |
|
|
379 | (1) |
|
3.4 Refinement of modeled structure |
|
|
379 | (1) |
|
4 Protein structure analysis and importance of protein folding |
|
|
380 | (3) |
|
5 Recent advances in in silico protein structure determination |
|
|
383 | (1) |
|
6 Conclusion and future perspectives |
|
|
383 | (4) |
|
|
383 | (4) |
|
24 Advances in structure-based virtual screening for drug discovery |
|
|
|
|
|
|
|
387 | (1) |
|
2 Drug design and the computers |
|
|
387 | (8) |
|
2.1 Molecular descriptor-based screening |
|
|
387 | (1) |
|
2.2 From HTS to structure-based virtual screening |
|
|
388 | (1) |
|
2.3 Structural imperatives for ligand-receptor coupling and virtual screening |
|
|
388 | (1) |
|
2.4 Structural inputs for SBVS |
|
|
389 | (1) |
|
2.5 Core foundations of structure-based virtual screening |
|
|
390 | (1) |
|
2.6 Higher dimensional search protocol in SBVS |
|
|
391 | (1) |
|
2.7 Macromolecular flexibility in SBVS |
|
|
391 | (1) |
|
2.8 Docking reference ligands, validation, and modeling access to receptors |
|
|
391 | (2) |
|
2.9 Typical protocol for performing SBVS |
|
|
393 | (2) |
|
3 Conclusion and future perspectives |
|
|
395 | (10) |
|
|
401 | (3) |
|
|
404 | (1) |
|
25 Methods and applications of machine learning in structure-based drug discovery |
|
|
|
|
|
|
|
Chandrashekar Narayanan Rahul |
|
|
|
|
|
|
405 | (1) |
|
2 Protein crystallography and Al-assisted drug discovery |
|
|
406 | (2) |
|
2.1 Evolution of protein crystallography in drug design |
|
|
406 | (1) |
|
2.2 Methods in FBDD and enhancements provided by ML |
|
|
406 | (1) |
|
2.3 Improvement of X-ray crystallography using ML |
|
|
407 | (1) |
|
2.4 Applications of ML in NMR method |
|
|
407 | (1) |
|
2.5 Applications of ML in cryoEM method |
|
|
407 | (1) |
|
3 Application of ML in protein structure prediction (in silico approach) |
|
|
408 | (7) |
|
|
408 | (4) |
|
|
412 | (1) |
|
|
413 | (1) |
|
|
414 | (1) |
|
|
415 | (14) |
|
4.1 Concepts in ligand-based virtual screening (LBVS) |
|
|
415 | (1) |
|
4.2 Concepts of structure-based virtual screening (SBVS) |
|
|
415 | (14) |
|
5 Conclusion and future perspectives |
|
|
429 | (10) |
|
|
430 | (1) |
|
|
430 | (5) |
|
|
435 | (4) |
|
26 Molecular dynamics simulations: Principles, methods, and applications in protein conformational dynamics |
|
|
|
|
|
|
|
439 | (1) |
|
2 Applications of MD simulations |
|
|
440 | (1) |
|
|
441 | (2) |
|
3.1 Hardware dependencies |
|
|
441 | (1) |
|
3.2 Software dependencies |
|
|
441 | (1) |
|
3.3 Structural coordinates |
|
|
441 | (1) |
|
3.4 Structural and dynamic parameters |
|
|
442 | (1) |
|
3.5 MD simulation settings and workflow |
|
|
442 | (1) |
|
|
443 | (4) |
|
4.1 Preparing the coordinates |
|
|
443 | (1) |
|
4.2 Defining and solvating the simulation box |
|
|
444 | (1) |
|
|
444 | (1) |
|
|
444 | (1) |
|
|
445 | (1) |
|
|
445 | (1) |
|
|
445 | (1) |
|
|
446 | (1) |
|
|
447 | (2) |
|
6 Utility of MD simulation: A case study on conformational dynamics of D-amino acid oxidase (DAAO) |
|
|
449 | (1) |
|
7 Conclusion and future perspectives |
|
|
449 | (6) |
|
|
450 | (1) |
|
|
451 | (4) |
|
27 Applications of molecular dynamics simulations in drug discovery |
|
|
|
|
|
455 | (1) |
|
2 Identification of protein conformation ensemble and drug binding site |
|
|
455 | (1) |
|
2.1 Identification of protein conformation ensemble |
|
|
456 | (1) |
|
2.2 Identification of drug binding site |
|
|
456 | (1) |
|
3 Modeling protein-drug interactions |
|
|
456 | (6) |
|
3.1 Molecular docking using MD force field functions |
|
|
456 | (1) |
|
3.2 Long timescale MD simulations |
|
|
457 | (1) |
|
3.3 MD simulations with enhanced sampling methods |
|
|
458 | (2) |
|
3.4 MM/PBSA and MM/GBSA binding free energy calculation |
|
|
460 | (1) |
|
3.5 Alchemical binding free energy calculation |
|
|
461 | (1) |
|
3.6 The integration of molecular docking and molecular dynamics simulations |
|
|
461 | (1) |
|
4 Modeling drug-membrane interactions |
|
|
462 | (1) |
|
5 Conclusion and future perspectives |
|
|
463 | (4) |
|
|
463 | (4) |
|
28 Envisaging the conformational space of proteins by coupling machine learning and molecular dynamics |
|
|
|
|
|
|
467 | (1) |
|
2 Conformational impact due to various environment |
|
|
468 | (1) |
|
3 Multiple conformational states of proteins |
|
|
468 | (1) |
|
4 Impact of Ramachandran plot in conformational space |
|
|
469 | (1) |
|
5 Variability in the conformation of intrinsically disordered proteins |
|
|
470 | (1) |
|
6 Conformational sampling analysis through different methods |
|
|
470 | (1) |
|
7 Role of force fields in different conformational space observation |
|
|
470 | (1) |
|
8 Conformational space assessment on the explicit and implicit solvent model |
|
|
471 | (1) |
|
9 Conformational space analysis through machine learning |
|
|
472 | (1) |
|
10 Combination of MD simulation and machine learning |
|
|
472 | (1) |
|
11 Conclusion and future perspectives |
|
|
472 | (5) |
|
|
472 | (1) |
|
Declaration of competing interests |
|
|
473 | (1) |
|
|
473 | (4) |
|
29 Immunoinformatics and reverse vaccinology methods to design peptide-based vaccines |
|
|
|
|
|
|
|
|
477 | (1) |
|
|
477 | (2) |
|
3 Methods and tools in reverse vaccinology |
|
|
479 | (4) |
|
3.1 T-cell epitope mapping |
|
|
479 | (2) |
|
3.2 Prediction of MHC polymorphism in T-cell epitope mapping |
|
|
481 | (1) |
|
3.3 B-cell epitope mapping |
|
|
481 | (1) |
|
|
481 | (1) |
|
3.5 Analysis of the designed vaccine |
|
|
482 | (1) |
|
3.6 Molecular docking and molecular dynamics simulation |
|
|
483 | (1) |
|
3.7 Immune dynamics (ID) simulation of the designed vaccine candidate |
|
|
483 | (1) |
|
4 Steps involved in reverse vaccinology |
|
|
483 | (1) |
|
5 Advantage of peptide vaccine or multi-epitope vaccines |
|
|
484 | (1) |
|
6 Conclusion and future perspectives |
|
|
485 | (4) |
|
|
485 | (4) |
|
30 Computational methods to study intrinsically disordered proteins |
|
|
|
|
|
|
|
|
|
489 | (3) |
|
1.1 Two decades of IDP research |
|
|
490 | (1) |
|
1.2 IDPs in diseases, misfunctioning, and viral infections |
|
|
490 | (2) |
|
2 Bioinformatics over biophysical techniques to study IDP |
|
|
492 | (1) |
|
2.1 Usage of machine learning approaches in disorder predictors and structure modeling servers |
|
|
492 | (1) |
|
2.2 IDPs from the lens of molecular modeling and simulations |
|
|
493 | (1) |
|
3 Common predictors for identification of IDPs |
|
|
493 | (5) |
|
3.1 PONDR (predictor of naturally disordered regions) |
|
|
493 | (2) |
|
|
495 | (1) |
|
|
495 | (1) |
|
|
496 | (1) |
|
|
496 | (1) |
|
|
496 | (1) |
|
|
496 | (1) |
|
|
497 | (1) |
|
|
497 | (1) |
|
|
497 | (1) |
|
|
497 | (1) |
|
|
497 | (1) |
|
|
498 | (1) |
|
4 Identification of molecular recognition features (MoRFs) |
|
|
498 | (2) |
|
|
499 | (1) |
|
|
499 | (1) |
|
|
499 | (1) |
|
|
499 | (1) |
|
5 Prediction of nucleic acid-binding regions |
|
|
500 | (1) |
|
|
500 | (1) |
|
|
500 | (1) |
|
|
500 | (1) |
|
6 Biological relevance of predictions |
|
|
501 | (1) |
|
7 Conclusion and future perspectives |
|
|
501 | (4) |
|
|
501 | (1) |
|
|
501 | (4) |
|
31 Experimental methods to study intrinsically disordered proteins |
|
|
|
|
|
|
|
|
|
505 | (1) |
|
2 Size exclusion chromatography |
|
|
505 | (1) |
|
|
506 | (1) |
|
3 UV-vis absorption spectroscopy |
|
|
506 | (1) |
|
|
507 | (1) |
|
4 Circular dichroism spectroscopy |
|
|
507 | (3) |
|
|
508 | (1) |
|
|
509 | (1) |
|
|
509 | (1) |
|
5 Fluorescence spectroscopy |
|
|
510 | (5) |
|
5.1 Intrinsic protein fluorescence |
|
|
511 | (1) |
|
5.2 Extrinsic fluorescence probes |
|
|
511 | (1) |
|
5.3 Fluorescence resonance energy transfer |
|
|
512 | (1) |
|
5.4 Fluorescence correlation spectroscopy |
|
|
513 | (1) |
|
5.5 Fluorescence anisotropy |
|
|
513 | (2) |
|
5.6 Fast relaxation imaging |
|
|
515 | (1) |
|
6 Nuclear magnetic resonance spectroscopy |
|
|
515 | (1) |
|
|
516 | (1) |
|
7 Fourier transform infrared spectroscopy |
|
|
516 | (1) |
|
|
517 | (1) |
|
|
517 | (1) |
|
8 Electron spin resonance spectroscopy |
|
|
517 | (2) |
|
|
518 | (1) |
|
|
519 | (2) |
|
|
520 | (1) |
|
10 Light scattering methods |
|
|
521 | (3) |
|
10.1 Static light scattering |
|
|
521 | (1) |
|
10.2 Dynamic light scattering |
|
|
521 | (1) |
|
10.3 Small-angle X-ray scattering |
|
|
522 | (2) |
|
11 Microscopy-based methods |
|
|
524 | (1) |
|
11.1 Atomic force microscopy |
|
|
524 | (1) |
|
12 Analytical ultracentrifugation |
|
|
525 | (2) |
|
|
527 | (1) |
|
|
527 | (3) |
|
|
528 | (1) |
|
|
529 | (1) |
|
14 Conclusions and future perspectives |
|
|
530 | (5) |
|
|
530 | (5) |
|
32 Analysis of structure and dynamics of intrinsically disordered regions in proteins using solution NMR methods |
|
|
|
|
|
|
|
|
535 | (1) |
|
2 NMR chemical shift assignments of intrinsically disordered sequences |
|
|
535 | (5) |
|
2.1 Standard backbone assignment strategy |
|
|
536 | (1) |
|
2.2 Backbone assignment using 13C detection |
|
|
537 | (1) |
|
2.3 Fast data acquisition to reduce experiment time |
|
|
537 | (1) |
|
2.4 Segmental isotope labeling of IDRPs |
|
|
538 | (1) |
|
2.5 Cell-free protein synthesis for IDRPs |
|
|
539 | (1) |
|
3 Structural characterization of IDRPs |
|
|
540 | (2) |
|
3.1 Chemical shift-based methods |
|
|
540 | (1) |
|
3.2 Residual dipolar coupling (RDC) |
|
|
540 | (1) |
|
3.3 Paramagnetic relaxation enhancement (PRE) |
|
|
541 | (1) |
|
3.4 Determination of ensemble structure of IDRPs |
|
|
541 | (1) |
|
4 Characterization of IDRP dynamics |
|
|
542 | (3) |
|
4.1 Measuring fast timescale (ps-ns) dynamics |
|
|
542 | (1) |
|
4.2 Identifying rigid segments in IDRPs |
|
|
543 | (1) |
|
4.3 Determination of global flexibility of disordered sequences |
|
|
544 | (1) |
|
4.4 Slow dynamics (us-ms) in IDRPs |
|
|
544 | (1) |
|
5 In-cell NMR experiments |
|
|
545 | (1) |
|
6 Conclusions and future perspectives |
|
|
546 | (5) |
|
|
546 | (5) |
|
33 Methods to study the effect of solution variables on the conformational dynamics of intrinsically disordered proteins |
|
|
|
|
|
|
|
|
551 | (1) |
|
2 Computational tools to study the impacts of solution variables on IDPs |
|
|
552 | (13) |
|
2.1 Density functional theory calculations |
|
|
552 | (2) |
|
2.2 Multiple MD simulations |
|
|
554 | (4) |
|
2.3 Deep neural networks: Generative neural networks |
|
|
558 | (3) |
|
|
561 | (4) |
|
34 Molecular simulations to study IDP-IDP interactions and their complexes |
|
|
|
|
1 Intrinsically disordered proteins and their interactions |
|
|
565 | (1) |
|
2 Introduction of the molecular simulation techniques |
|
|
566 | (1) |
|
3 Characterizing IDP-IDP interactions and their complexes by coarse-grained models |
|
|
567 | (3) |
|
3.1 Coarse-grained models for the LLPS |
|
|
567 | (1) |
|
3.2 Analyzing phase diagrams of the LLPS |
|
|
568 | (1) |
|
3.3 Sequence determinants for the LLPS: Ionic interactions |
|
|
568 | (2) |
|
3.4 Applications for other types of condensates |
|
|
570 | (1) |
|
4 Challenges in coarse-grained models |
|
|
570 | (3) |
|
4.1 Hydrogen bonds and secondary structure formation |
|
|
570 | (1) |
|
4.2 Treatment with Jt group interactions |
|
|
571 | (1) |
|
4.3 Treatment with solvents |
|
|
571 | (1) |
|
4.4 Limitations with the size of the simulation system |
|
|
571 | (1) |
|
4.5 Improvements of coarse-grained models and potentials |
|
|
572 | (1) |
|
5 Conclusion and future perspectives |
|
|
573 | (2) |
|
|
573 | (2) |
|
35 Exploring large-scale protein function using systematic mutant analysis |
|
|
|
|
|
|
|
|
|
575 | (1) |
|
2 Engineering systematic site saturation mutant libraries |
|
|
576 | (1) |
|
|
576 | (1) |
|
2.2 Site-directed mutagenesis |
|
|
576 | (2) |
|
3 Screening the systematic mutant libraries for variant function |
|
|
578 | (501) |
|
|
578 | (1) |
|
3.2 Fluorescence-based screening |
|
|
579 | (1) |
|
3.3 Coupling protein function to host cell fitness |
|
|
579 | (1) |
|
4 Next-generation sequencing of the variants |
|
|
579 | (1) |
|
5 Large-scale functional mapping in proteins |
|
|
580 | (5) |
|
|
581 | (2) |
|
5.2 Mutant effects on structure and stability of proteins |
|
|
583 | (1) |
|
5.3 Protein-protein interactions |
|
|
584 | (1) |
|
5.4 In silico prediction of mutant effects |
|
|
584 | (1) |
|
6 Conclusion and future perspectives |
|
|
585 | (4) |
|
|
585 | (1) |
|
|
585 | (4) |
|
36 Approaches and methods to study cell signaling: Linguistics of cellular communication |
|
|
|
|
|
|
589 | (1) |
|
2 Molecular players in signal transduction |
|
|
589 | (1) |
|
|
589 | (1) |
|
|
590 | (1) |
|
2.3 Intracellular messengers |
|
|
590 | (1) |
|
3 Cell signaling can occur in a variety of ways |
|
|
590 | (2) |
|
3.1 Signaling via soluble molecules |
|
|
590 | (2) |
|
3.2 Signaling via cell-cell direct contact or Juxtacrine signaling |
|
|
592 | (1) |
|
4 Cell signaling orchestrates key biological processes |
|
|
592 | (8) |
|
4.1 Cells can proliferate upon induction with long-range signaling by soluble molecules |
|
|
592 | (1) |
|
4.2 Insulin signaling controls various metabolic activities of the cell |
|
|
593 | (2) |
|
4.3 Cell signaling by morphogens and growth factors orchestrate embryonic development |
|
|
595 | (1) |
|
4.4 The RTK pathway regulates a wide array of developmental cellular processes |
|
|
595 | (1) |
|
4.5 Wnt signaling pathway regulates proliferation and differentiation of stem cells |
|
|
596 | (1) |
|
4.6 Sonic hedgehog signaling is vital for the normal development of different organs |
|
|
597 | (1) |
|
4.7 Notch signaling regulates binary cell fate decisions, proliferation, and differentiation |
|
|
597 | (1) |
|
4.8 Cell migration is induced by several growth factors that primarily act through mitogen-activated protein kinase (MAPK) cascades |
|
|
598 | (1) |
|
4.9 Death receptor signaling leads to apoptotic cell death |
|
|
599 | (1) |
|
5 Experimental techniques used to study cell signaling |
|
|
600 | (18) |
|
5.1 Biochemical approaches to study signal transduction |
|
|
600 | (5) |
|
5.2 Studying signaling events in live cells |
|
|
605 | (5) |
|
5.3 Experimental techniques for studying second messengers involved in cell signaling |
|
|
610 | (2) |
|
5.4 Techniques for detection and measurement of intracellular calcium |
|
|
612 | (2) |
|
5.5 Phosphoproteomics: Global approaches to studying cell signaling |
|
|
614 | (4) |
|
6 Conclusion and future perspectives |
|
|
618 | (7) |
|
|
618 | (7) |
|
37 Methods to study systems biology of signaling networks: A case study of NSCLC |
|
|
|
|
|
|
625 | (1) |
|
2 Non-small cell lung carcinoma (NSCLC) |
|
|
625 | (1) |
|
|
626 | (1) |
|
4 Applications of systems biology approaches in cancer studies |
|
|
627 | (1) |
|
5 System biology methods and approaches |
|
|
628 | (1) |
|
5.1 Reconstruction of signaling network |
|
|
628 | (1) |
|
|
628 | (1) |
|
|
628 | (1) |
|
|
628 | (1) |
|
5.5 Principle component analysis |
|
|
628 | (1) |
|
|
629 | (1) |
|
|
629 | (1) |
|
6.1 Model reconstruction and simulation |
|
|
629 | (1) |
|
6.2 Principal component analysis (PCA) |
|
|
629 | (1) |
|
|
629 | (1) |
|
|
629 | (1) |
|
7 Interpretations and conclusions |
|
|
629 | (6) |
|
|
633 | (1) |
|
|
633 | (2) |
|
38 Advancements in the analysis of protein post-translational modifications |
|
|
|
|
|
|
|
|
635 | (1) |
|
|
635 | (1) |
|
3 Types of ubiquitination |
|
|
636 | (1) |
|
4 Detection of protein ubiquitination |
|
|
636 | (1) |
|
4.1 Immunoprecipitation and immunoblotting |
|
|
636 | (1) |
|
4.2 Identification of ubiquitinated proteins with a ubiquitin-specific affinity resin |
|
|
636 | (1) |
|
4.3 Efficient isolation of ubiquitylated proteins using tandem ubiquitin-binding entities (TUBEs) |
|
|
637 | (1) |
|
4.4 Modification of TUBEs |
|
|
637 | (1) |
|
4.5 Detection of polyubiquitination by the luminescent method |
|
|
637 | (1) |
|
5 Identification of the site of ubiquitination |
|
|
637 | (1) |
|
5.1 Site-directed mutagenesis |
|
|
637 | (1) |
|
5.2 Mass spectrometric analysis |
|
|
638 | (1) |
|
6 Ubiquitin chain architecture detection |
|
|
638 | (1) |
|
7 Conclusion and future perspectives |
|
|
639 | (2) |
|
|
639 | (2) |
|
39 Protein engineering: Methods and applications |
|
|
|
|
|
|
641 | (1) |
|
2 Protein engineering approaches |
|
|
641 | (1) |
|
|
641 | (12) |
|
3.1 Nonrecombination methods (asexual methods) |
|
|
642 | (3) |
|
3.2 Recombination methods |
|
|
645 | (8) |
|
|
653 | (1) |
|
4.1 Structure-based combinatorial protein engineering (SCOPE) |
|
|
653 | (1) |
|
|
653 | (1) |
|
|
654 | (2) |
|
6.1 Identification of sites (amino acid residues) for modification |
|
|
655 | (1) |
|
6.2 Multiple sequence alignment (MSA) |
|
|
655 | (1) |
|
6.3 Co-evolutionary analysis |
|
|
655 | (1) |
|
|
655 | (1) |
|
6.5 Site-directed mutagenesis (SDM) |
|
|
655 | (1) |
|
7 Applications of protein engineering |
|
|
656 | (5) |
|
7.1 Protein engineering for industrial enzymes |
|
|
656 | (4) |
|
7.2 Protein engineering in healthcare |
|
|
660 | (1) |
|
7.3 Protein engineering in metabolic pathway engineering (MPE) |
|
|
661 | (1) |
|
|
661 | (8) |
|
|
662 | (7) |
|
40 Designer 3D-DNA nanodevices: Structures, functions, and cellular applications |
|
|
|
|
|
|
|
|
669 | (1) |
|
2 Different approaches to realize 3D DNA polyhedral nanodevices |
|
|
670 | (1) |
|
2.1 One-pot synthesis method |
|
|
670 | (1) |
|
2.2 Modular assembly method |
|
|
671 | (1) |
|
2.3 Origami-based assembly |
|
|
671 | (1) |
|
3 Methods for characterization of DNA nanostructures |
|
|
671 | (2) |
|
3.1 Electrophoretic mobility shift assay |
|
|
671 | (1) |
|
3.2 Dynamic light scattering |
|
|
672 | (1) |
|
3.3 High-performance liquid chromatography |
|
|
673 | (1) |
|
3.4 Atomic force microscopy |
|
|
673 | (1) |
|
3.5 Transmission electron microscopy |
|
|
673 | (1) |
|
4 Cellular uptake of TDN and its characterization |
|
|
673 | (1) |
|
5 Conclusions and future perspectives |
|
|
674 | (3) |
|
|
675 | (1) |
|
|
675 | (1) |
|
|
675 | (2) |
Index |
|
677 | |